- Cullman, Alabama


September 28, 2012

Ala. doctor has a promising pain relief theory

TUSCALOOSA — There may be treatment on the horizon for patients suffering from fibromyalgia, a chronic pain condition.

Clinical trials that may begin as early as February could prove Tuscaloosa-based surgeon Dr. William “Skip” Pridgen’s theory that fibromyalgia, other chronic pain conditions and many gastrointestinal disorders are all caused by the same virus. The trials will also test a pain-treatment therapy for fibromyalgia, the most severe of those.

In addition, Dr. Carol Duffy, a University of Alabama assistant professor in the biological sciences department, will research lab results in the hopes that it will lead to a diagnostic tool for physicians.

“Some of these patients’ stories are just heartbreaking. They are in a lot of pain, they can’t work anymore, are on disability,” Duffy said. “There’s a real need for this, and I really hope this is the answer. It will give a lot of people a much better quality of life.”

Pridgen began developing his theory more than 10 years ago, when he noticed many of his patients with gastrointestinal issues had recurring symptoms that appeared to get worse during times of stress. After some research, he concluded those problems may be caused by the herpes simplex virus, the same virus that causes cold sores, and prescribed an anti-viral drug. At the same time, some of those patients also complained of other symptoms, for which he prescribed another anti-viral medication. When the patients returned, not only were their GI symptoms better, but other problems like depression, chronic fatigue and fibromyalgia were also improving with the drug combination.

Pridgen started working with Duffy, who studies how viruses replicate, in creating a randomized trial that will be funded by a start-up company the two started. Pridgen estimates the Phase II clinical trial, which will involve 140 fibromyalgia patients at 10 sites around the county, will take about a year.

Using blood samples from the clinical trial participants, Duffy will measure cytokine levels. Cytokines are signaling molecules that flow through the body’s bloodstream and are produced at different levels and types based on what the body is experiencing. Studies show that patients with fibromyalgia have elevated levels of one type of cytokine and lower levels of another. Because a fibromyalgia diagnosis presently is based on a patient’s subjective responses to a physician’s questions about their pain, Duffy said by studying the cytokine levels, she can see if there is a correlation between those levels and the patient’s reported pain levels.

“If the (clinical trial patients) are on the medication and they improve, then we can hypothesize that their self-reported pain levels will decrease and their cytokine levels will normalize,” Duffy said. “Not only will they say they are feeling better, but there will be some concrete data that shows their levels have stabilized.”

If results from the Phase II trial are positive, the next step would be Phase III trials, which involve thousands of patients. Duffy said at that point they will approach pharmaceutical companies about purchasing the patent and those companies will complete the final trials, as well as try for approval to get the drug on the market.

“Whoever ends up buying the patent will be able to pursue this treatment for other chronic pain conditions, irritable bowel syndrome, headaches and more,” Pridgen said. “If this proves what we think it will, it is going to change the way people think about chronic pain and chronic conditions. It will have a huge impact on a lot of people.”


Text Only
  • COMMENTARY: An alternative diagnosis to ADHD: Schoolchildren need more time to move

    The Centers for Disease Control and Prevention tells us that in recent years, there has been a jump in the percentage of young people diagnosed with attention deficit and hyperactivity disorder, commonly known as ADHD: 7.8 percent in 2003 to 9.5 percent in 2007 to 11 percent in 2011.

    July 18, 2014

  • Guideline: Most healthy women can skip pelvic exam

    No more dreaded pelvic exam? New guidelines say most healthy women can skip the yearly ritual.

    July 1, 2014

  • Sanofi targets fake Viagra market with non-prescription Cialis

    Sanofi sees an attractive opportunity in the rampant market for counterfeit Viagra: luring men away from dodgy online pharmacies with an over-the-counter version of a competing erection drug.

    June 5, 2014

  • Hospital charges to treat chest pain jump 10 percent in a year

    The charge to treat Medicare patients with chest pain at U.S. hospitals rose 10 percent to $18,568 in just a year, the biggest rise seen among the most common inpatient procedures, according to federal data.

    June 2, 2014

  • Study: Both men and women feel less stress at work than at home

    In a newly released study in the Journal of Science and Medicine, researchers carefully examined the levels of the stress hormone, cortisol, of a variety of workers throughout the day. The data clearly showed that both men and women are significantly less stressed out at work than they are at home.
     And the women they studied said they were happier at work. While the men said they felt happier at home.

    May 26, 2014

  • Jobless contend with weight gain as they search for work

    A subject long ignored by policymakers, and one that unemployment counselors are too sheepish to raise with job seekers, the link between bulging waistlines and joblessness is now of intense interest to researchers studying the long-term effects of the country's economic malaise.

    May 12, 2014

  • COMMENTARY: Helmets won't protect your kids from concussions

    When I was a kid, helmets were for motorcyclists. Now I see children wearing helmets when they're scooting down sidewalks, skating, skiing, sledding and playing soccer. Last week one of my friends saw a helmeted kid power-walking in Prospect Park. You can even buy $40 baby helmets on Amazon, because, according to the product description, "babies will always fall taking their first steps."

    May 2, 2014

  • 400px-Cannabis_Plant.jpg How bad is marijuana for your health?

    The Journal of Neuroscience recently published a study linking recreational marijuana use to subtle changes in brain structure. The researchers, led by Jodi Gilman of Massachusetts General Hospital, identified increased gray matter density in the left nucleus accumbens and some bordering areas.

    May 1, 2014 1 Photo

  • American sunscreens need an upgrade

    The last time a new sunscreen ingredient came on the U.S. market, the Y2K bug was threatening to destroy our way of life. Intel had just introduced the Pentium III processor, featuring an amazing 500 MHz of computing power.

    April 24, 2014

  • Cuba is running out of condoms

    The newest item on Cuba's list of dwindling commodities is condoms, which are now reportedly in short supply. In response, the Cuban government has approved the sale of expired condoms.

    April 23, 2014